Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 204

The DOI matches its Crossref record.

Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer

Buijs, Jeroen T., Henriquez, Nico V., van Overveld, Petra G.M., van der Horst, Geertje, Que, Ivo, Schwaninger, Ruth, Rentsch, Cyrill, ten Dijke, Peter, Cleton-Jansen, Anne-Marie, Driouch, Keltouma, Lidereau, Rosette, Bachelier, Richard, Vukicevic, Slobodan, Clézardin, Philippe, Papapoulos, Socrates E., Cecchini, Marco G., Löwik, Clemens W.G.M., van der Pluijm, Gabri·2007·Cancer Research

Abstract

Bone morphogenetic protein 7 (BMP7) counteracts the physiological epithelial-to-mesenchymal transition (EMT), a process that is indicative of epithelial plasticity. Because EMT is involved in cancer, we investigated whether BMP7 plays a role in breast cancer growth and metastasis. In this study, we show that decreased BMP7 expression in primary breast cancer is significantly associated with the formation of clinically overt bone metastases in patients with ≥10 years of follow-up. In line with these clinical observations, BMP7 expression is inversely related to tumorigenicity and invasive behavior of human breast cancer cell lines. Moreover, BMP7 decreased the expression of vimentin, a mesenchymal marker associated with invasiveness and poor prognosis, in human MDA-MB-231 (MDA-231)-B/Luc+ breast cancer cells under basal and transforming growth factor-β (TGF-β)–stimulated conditions. In addition, exogenous addition of BMP7 to TGF-β–stimulated MDA-231 cells inhibited Smad-mediated TGF-β signaling. Furthermore, in a well-established bone metastasis model using whole-body bioluminescent reporter imaging, stable overexpression of BMP7 in MDA-231 cells inhibited de novo formation and progression of osteolytic bone metastases and, hence, their metastatic capability. In line with these observations, daily i.v. administration of BMP7 (100 μg/kg/d) significantly inhibited orthotopic and intrabone growth of MDA-231-B/Luc+ cells in nude mice. Our data suggest that decreased BMP7 expression during carcinogenesis in the human breast contributes to the acquisition of a bone metastatic phenotype. Because exogenous BMP7 can still counteract the breast cancer growth at the primary site and in bone, BMP7 may represent a novel therapeutic molecule for repression of local and bone metastatic growth of breast cancer. [Cancer Res 2007;67(18):8742–51]

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-06-2490

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 204

Metadata

Authors
Buijs, J. T., Henriquez, N. V., van Overveld, P. G. M., van der Horst, G., Que, I., Schwaninger, R., Rentsch, C., ten Dijke, P., Cleton-Jansen, A.-M., Driouch, K., Lidereau, R., Bachelier, R., Vukicevic, S., Clézardin, P., Papapoulos, S. E., Cecchini, M. G., Löwik, C. W. G. M., & van der Pluijm, G.
Venue
Cancer Research
Published
2007-09-15
Volume
67
Issue
18
Pages
8742-8751
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2159000413
Cited by
204
References
0
FWCI
6.82
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-06-2490
The paper
Buijs, J. T., Henriquez, N. V., van Overveld, P. G. M., van der Horst, G., Que, I., Schwaninger, R., Rentsch, C., ten Dijke, P., Cleton-Jansen, A.-M., Driouch, K., Lidereau, R., Bachelier, R., Vukicevic, S., Clézardin, P., Papapoulos, S. E., Cecchini, M. G., Löwik, C. W. G. M., & van der Pluijm, G. (2007). Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-06-2490

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.